References: Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD.IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.J Immunol. 2006 Jan 15;176(2):905-13.
Bahram S, Inoko H, Shiina T, Radosavljevic M.MIC and other NKG2D ligands: from none to too many.Curr Opin Immunol. 2005 Oct;17(5):505-9.
Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S.NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.J Exp Med. 2005 Jan 17;201(2):211-20. Epub 2005 Jan 10.
Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.Nat Immunol. 2000 Aug;1(2):119-26.